SPATS1
Spermatogenesis-associated serine-rich protein 1
Also known as: FLJ25442, SPAS1_HUMAN, SPATA8, SRSP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q496A3
- Gene
- SPATS1
- Ensembl
- ENSG00000249481
- Chromosome
- 6
- Canonical length
- 300 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
No narrative summary is available for SPATS1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
300 residues, UniProt reviewed canonical sequence.
>Q496A3|SPATS1
1 MSPSMLTGNS PRGCRLPSIS STTCGRQLEK VPEKRDSGMT EVERTYSANC SDFLESKGCF
61 ANTTPSGKSV SSSSSVETGP SVSEPPGLPR VSAYVDTTAD LDRKLSFSHS DHSSEMSLPE
121 VQKDKYPEEF SLLKLQTKDG HRPEWTFYPR FSSNIHTYHV GKQCFFNGVF LGNKRSLSER
181 TVDKCFGRKK YDIDPRNGIP KLTPGDNPYM YPEQSKGFHK AGSMLPPVNF SIVPYEKKFD
241 TFIPLEPLPQ IPNLPFWVKE KANSLKNEIQ EVEELDNWQP AVPLMHMLHL SGALDFPRQSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPATS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- fallopian tube: 7.2 nTPM
- epididymis: 5.5 nTPM
- choroid plexus: 1 nTPM
- basal ganglia: 0.7 nTPM
- hippocampal formation: 0.7 nTPM
Single-cell type
- late spermatids: 26 nCPM
- early spermatids: 25 nCPM
- late primary spermatocytes: 23 nCPM
- ependymal cells: 11 nCPM
- respiratory ciliated cells: 7.2 nCPM
- epididymal efferent duct ciliated cells: 4.2 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- basophil: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
Brain region
- midbrain: 4.6 nTPM
- medulla oblongata: 3.4 nTPM
- white matter: 3.1 nTPM
- spinal cord: 3 nTPM
- hippocampal formation: 1.8 nTPM
- hypothalamus: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Spermatogenesis-associated serine-rich protein 1
- Spermatogenesis-associated serine-rich protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPATS1 as an antibody target. Whether an autoantibody or antibody against SPATS1 could matter depends on whether native SPATS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPATS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPATS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...